Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Molecular Biology›DNA Cleavage
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

DNA Cleavage

Molecular Biology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

A reaction that severs one of the covalent sugar-phosphate linkages between nucleotides that compose the sugar phosphate backbone of DNA.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (730 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A reaction that severs one of the covalent sugar-phosphate linkages between nucleotides that compose the sugar phosphate backbone of DNA. It is catalyzed enzymatically, chemically or by radiation. Cleavage may be exonucleolytic - removing the end nucleotide, or endonucleolytic - splitting the strand in two.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Biochemical Phenomena; Genetic Phenomena

Related concepts

  • Nucleotides

Research landscape

PubMed indexes 2,118 records tagged with the MeSH heading “DNA Cleavage” (counts retrieved 2026-10-29). 451 of them (21.3%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 1,450 records.

Reviews account for 71 records (3.4%) and meta-analyses for 0. Randomized controlled trials number 0 (0.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 257 records; 2010-2019: 1,450 records; 2020 onward: 451 records0through 19992572000-20091,4502010-20194512020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-2009257
2010-20191,450
2020 onward451
Share of records by publication typeReviews: 3.4 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.0 percentReviews3.4% (71)Meta-analyses0.0% (0)Randomized controlled trials0.0% (0)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,118 PubMed records
TypeRecordsShare
Reviews713.4%
Meta-analyses00.0%
Randomized controlled trials00.0%

Method: PubMed query "DNA Cleavage"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in molecular biology

Molecular biology establishes mechanisms through controlled experiments, often in simplified systems such as purified proteins, cultured cells or model organisms. Such work can show what is possible in a defined system, but whether a pathway matters in a whole organism or in human disease needs further evidence. Check the experimental system, whether findings were reproduced by independent groups, and whether the authors tested the mechanism directly or inferred it from correlation.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage
Zhang JP, Li XL, Li GH, Chen W, Arakaki C, Botimer GD, et al.
2017Research article
Design not recorded in structured metadata
402cc by
PMID 28219395 · DOI · PMC5319046
Tight nuclear tethering of cGAS is essential for preventing autoreactivity
Volkman HE, Cambier S, Gray EE, Stetson DB
2019Research article
Design not recorded in structured metadata
271cc by
PMID 31808743 · DOI · PMC6927687
A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
Dagdas YS, Chen JS, Sternberg SH, Doudna JA, Yildiz A
2017Research article
Design not recorded in structured metadata
249cc by
PMID 28808686 · DOI · PMC5547770
Rapid DNA cleavage by the LINE-1 endonuclease proximal to DNA ends and at mismatches
Miller BD, Smail BA, Van Eeuwen T, Kodama H, Kondo K, Jiang H, et al.
2026Research article
Design not recorded in structured metadata
3cc by
PMID 41325800 · DOI · PMC12809410

Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage [1]

Research article Zhang JP, Li XL, Li GH, Chen W, Arakaki C, Botimer GD, et al. · · 2017 · cited 402 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundPrecise genome editing via homology-directed repair (HDR) after double-stranded DNA (dsDNA) cleavage facilitates functional genomic research and holds promise for gene therapy.
Closing excerpt
ConclusionsTaken together, these findings provide guidance for the design of HDR donor vectors and the selection of HDR-enhancing factors for applications in genome research and precision medicine.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (176 words)

BackgroundPrecise genome editing via homology-directed repair (HDR) after double-stranded DNA (dsDNA) cleavage facilitates functional genomic research and holds promise for gene therapy. However, HDR efficiency remains low in some cell types, including some of great research and clinical interest, such as human induced pluripotent stem cells (iPSCs).ResultsHere, we show that a double cut HDR donor, which is flanked by single guide RNA (sgRNA)-PAM sequences and is released after CRISPR/Cas9 cleavage, increases HDR efficiency by twofold to fivefold relative to circular plasmid donors at one genomic locus in 293 T cells and two distinct genomic loci in iPSCs. We find that a 600 bp homology in both arms leads to high-level genome knockin, with 97-100% of the donor insertion events being mediated by HDR. The combined use of CCND1, a cyclin that functions in G1/S transition, and nocodazole, a G2/M phase synchronizer, doubles HDR efficiency to up to 30% in iPSCs.ConclusionsTaken together, these findings provide guidance for the design of HDR donor vectors and the selection of HDR-enhancing factors for applications in genome research and precision medicine.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28219395 · DOI · PMC5319046

Tight nuclear tethering of cGAS is essential for preventing autoreactivity [2]

Research article Volkman HE, Cambier S, Gray EE, Stetson DB · · 2019 · cited 271 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
cGAS is an intracellular innate immune sensor that detects double-stranded DNA.
Closing excerpt
Thus, tight nuclear tethering maintains the resting state of cGAS and prevents autoreactivity.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (151 words)

cGAS is an intracellular innate immune sensor that detects double-stranded DNA. The presence of billions of base pairs of genomic DNA in all nucleated cells raises the question of how cGAS is not constitutively activated. A widely accepted explanation for this is the sequestration of cGAS in the cytosol, which is thought to prevent cGAS from accessing nuclear DNA. Here, we demonstrate that endogenous cGAS is predominantly a nuclear protein, regardless of cell cycle phase or cGAS activation status. We show that nuclear cGAS is tethered tightly by a salt-resistant interaction. This tight tethering is independent of the domains required for cGAS activation, and it requires intact nuclear chromatin. We identify the evolutionarily conserved tethering surface on cGAS and we show that mutation of single amino acids within this surface renders cGAS massively and constitutively active against self-DNA. Thus, tight nuclear tethering maintains the resting state of cGAS and prevents autoreactivity.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 31808743 · DOI · PMC6927687

A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9 [3]

Research article Dagdas YS, Chen JS, Sternberg SH, Doudna JA, Yildiz A · · 2017 · cited 249 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The Cas9 endonuclease is widely used for genome engineering applications by programming its single-guide RNA, and ongoing work is aimed at improving the accuracy and efficiency of DNA targeting.
Closing excerpt
Sequence mismatches between the DNA target and guide RNA prevent transitions from the checkpoint intermediate to the active conformation, providing selective avoidance of DNA cleavage at stably bound off-target sites.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (151 words)

The Cas9 endonuclease is widely used for genome engineering applications by programming its single-guide RNA, and ongoing work is aimed at improving the accuracy and efficiency of DNA targeting. DNA cleavage of Cas9 is controlled by the conformational state of the HNH nuclease domain, but the mechanism that governs HNH activation at on-target DNA while reducing cleavage activity at off-target sites remains poorly understood. Using single-molecule Förster resonance energy transfer, we identified an intermediate state of Streptococcus pyogenes Cas9, representing a conformational checkpoint between DNA binding and cleavage. Upon DNA binding, the HNH domain transitions between multiple conformations before docking into its active state. HNH docking requires divalent cations, but not strand scission, and this docked conformation persists following DNA cleavage. Sequence mismatches between the DNA target and guide RNA prevent transitions from the checkpoint intermediate to the active conformation, providing selective avoidance of DNA cleavage at stably bound off-target sites.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28808686 · DOI · PMC5547770

Rapid DNA cleavage by the LINE-1 endonuclease proximal to DNA ends and at mismatches [4]

Research article Miller BD, Smail BA, Van Eeuwen T, Kodama H, Kondo K, Jiang H, et al. · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Long interspersed element 1 (LINE-1, L1) is a eukaryotic retrotransposon that propagates through an RNA intermediate.
Closing excerpt
Together, these results indicate that EN cleavage is based primarily on DNA structure rather than sequence, that many L1 insertion attempts likely fail after cleavage at the priming step , and that mismatches and possibly other DNA conformational alterations promote EN cleavage, broadening our understanding of the genomic impact of L1.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (252 words)

Long interspersed element 1 (LINE-1, L1) is a eukaryotic retrotransposon that propagates through an RNA intermediate. Its mutagenic insertion mechanism, target-primed reverse transcription (TPRT), requires coordinated activities of the encoded ORF2 protein (ORF2p) endonuclease (EN) and reverse transcriptase (RT) domains. EN initiates TPRT by nicking target genomic DNA, creating a 3'-OH that primes ORF2p RT for complementary DNA synthesis using the bound L1 RNA template. L1 insertions occur preferentially at 5'-TTTTT↓AA consensus motifs; this bias could reflect site-specific EN cleavage or sequence requirements in the subsequent RT priming step, in which the cut genomic DNA flap must base pair with the poly(A) RNA template. We find that, in vitro, EN is promiscuous, cutting linear DNA oligonucleotides and plasmids at many non-consensus sites. We discovered a cleavage activity on a mismatched substrate that was nicked ∼40-fold faster than duplex DNA containing the consensus site and identify three features promoting rapid cutting. First, EN cleaves two nucleotides downstream of mismatches, favoring A-G mismatches or T•G/U•G wobble pairs. Second, both mismatch and consensus sequences are cleaved >2-fold faster when proximal to a DNA end. Third, end-proximal EN cutting depends on end composition: 5' overhangs cut fastest, followed by 3' overhangs, followed by blunt ends. Together, these results indicate that EN cleavage is based primarily on DNA structure rather than sequence, that many L1 insertion attempts likely fail after cleavage at the priming step , and that mismatches and possibly other DNA conformational alterations promote EN cleavage, broadening our understanding of the genomic impact of L1.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41325800 · DOI · PMC12809410

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Natural and engineered nicking endonucleases--from cleavage mechanism to engineering of strand-specificity [5]
    Chan SH, Stoddard BL, Xu SY · Nucleic Acids Res · 2011 · cited 107 times (Europe PMC)
  • Research article DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion [6]
    Bax BD, Murshudov G, Maxwell A, Germe T · J Mol Biol · 2019 · cited 104 times (Europe PMC)
  • Research article Using CRISPR-Cas systems as antimicrobials [7]
    Bikard D, Barrangou R · Curr Opin Microbiol · 2017 · cited 87 times (Europe PMC)
  • Research article Making the cut(s): how Cas12a cleaves target and non-target DNA [8]
    Swarts DC · Biochem Soc Trans · 2019 · cited 57 times (Europe PMC)
  • Research article Type III CRISPR-Cas systems: when DNA cleavage just isn't enough [9]
    Pyenson NC, Marraffini LA · Curr Opin Microbiol · 2017 · cited 53 times (Europe PMC)
  • Research article DNA binding, photocleavage, and topoisomerase inhibition of functionalized ruthenium(II)-polypyridine complexes [10]
    Gao F, Chao H, Ji LN · Chem Biodivers · 2008 · cited 39 times (Europe PMC)

References

  1. Zhang JP, Li XL, Li GH, Chen W, Arakaki C, Botimer GD, et al.. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage. . 2017. PMID 28219395 · DOI · PMC5319046
  2. Volkman HE, Cambier S, Gray EE, Stetson DB. Tight nuclear tethering of cGAS is essential for preventing autoreactivity. . 2019. PMID 31808743 · DOI · PMC6927687
  3. Dagdas YS, Chen JS, Sternberg SH, Doudna JA, Yildiz A. A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9. . 2017. PMID 28808686 · DOI · PMC5547770
  4. Miller BD, Smail BA, Van Eeuwen T, Kodama H, Kondo K, Jiang H, et al.. Rapid DNA cleavage by the LINE-1 endonuclease proximal to DNA ends and at mismatches. . 2026. PMID 41325800 · DOI · PMC12809410
  5. Chan SH, Stoddard BL, Xu SY. Natural and engineered nicking endonucleases--from cleavage mechanism to engineering of strand-specificity. Nucleic Acids Res. 2011. PMID 20805246 · DOI · PMC3017599
  6. Bax BD, Murshudov G, Maxwell A, Germe T. DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion. J Mol Biol. 2019. PMID 31301408 · DOI · PMC6723622
  7. Bikard D, Barrangou R. Using CRISPR-Cas systems as antimicrobials. Curr Opin Microbiol. 2017. PMID 28888103 · DOI
  8. Swarts DC. Making the cut(s): how Cas12a cleaves target and non-target DNA. Biochem Soc Trans. 2019. PMID 31671185 · DOI
  9. Pyenson NC, Marraffini LA. Type III CRISPR-Cas systems: when DNA cleavage just isn't enough. Curr Opin Microbiol. 2017. PMID 28865392 · DOI
  10. Gao F, Chao H, Ji LN. DNA binding, photocleavage, and topoisomerase inhibition of functionalized ruthenium(II)-polypyridine complexes. Chem Biodivers. 2008. PMID 18972534 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • DNA FragmentationGenetics and Genomics
  • NucleotidesDrugs and Chemicals
  • DNA Mismatch RepairMolecular Biology
  • Pyrimidine DimersGenetics and Genomics
  • DNA AdductsGenetics and Genomics
  • DNA RepairMolecular Biology

All 100 articles in Molecular Biology →

At a glance

2,118
PubMed records on this heading
21%
published since 2020
71
review articles
0
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • DNA FragmentationGenetics and Genomics
  • NucleotidesDrugs and Chemicals
  • DNA Mismatch RepairMolecular Biology
  • Pyrimidine DimersGenetics and Genomics
  • DNA AdductsGenetics and Genomics

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support